» Articles » PMID: 28233117

Crystal Arthritides - Gout and Calcium Pyrophosphate Arthritis : Part 1: Epidemiology and Pathophysiology

Overview
Publisher Springer
Specialty Geriatrics
Date 2017 Feb 25
PMID 28233117
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Gout and calcium pyrophosphate deposition disease (CPPD, pseudogout) are still the most frequent inflammatory arthritides in multimorbid elderly patients. Gout and CPPD are different diseases and based on different pathophysiological principles. Gout is closely associated with the metabolic syndrome and is an independent risk factor for cardiovascular mortality. The prevalence of asymptomatic hyperuricemia is estimated to be 10-20% of adults in industrial nations and prevalence is strongly associated with age. More than 7% of persons aged over 65 years suffer from clinically manifest gout. The underlying pathophysiological principle is an imbalance between the formation and elimination of uric acid. The degradation of the purine bases adenine and guanosine to uric acid is catalysed by xanthine oxidase and genetic polymorphisms and mutations play an important role in absorption and excretion processes. Furthermore, carrier proteins, such as URAT-1 or OAT-4 also have an influence on these processes. An imbalance of the physiological processes results in the solubility product being exceeded, which in consequence leads to crystallization of urate. This induces a cascade of massive inflammatory reactions at the molecular and cellular level with the activation of cytokines. The inflammatory process can be stopped by neutrophil extracellular traps (NETs) that modulate aggregation and degradation of chemokines and cytokines and partitioning of crystallized urate against immune cells. Calcium pyrophosphate dehydrate (CPP) crystals are formed in the cartilage and CPP deposition can be found in 30% of people aged over 80 years. Inorganic pyrophosphate (PPi) is synthesized in chondrocytes and plays an important part in the formation of calcium pyrophosphate crystals. The degradation is catalyzed by inorganic pyrophosphatases. If there is dysregulation of this homeostasis more PPi is produced, which ultimately contributes to the formation of the CPP crystals.

Citing Articles

Comprehensive analysis of rheumatic diseases, comorbidities, and mortality in geriatric population: Real-world data of 515 patients in a single rheumatology clinic.

Tekeoglu S Medicine (Baltimore). 2024; 103(48):e40753.

PMID: 39612436 PMC: 11608722. DOI: 10.1097/MD.0000000000040753.


Chinese classical decoction Wuwei Xiaodu Drink alleviates gout arthritis by suppressing NLRP3-Mediated inflammation.

Lin N, Dai Q, Zhang Y, Xu L Front Pharmacol. 2024; 15:1388753.

PMID: 39130631 PMC: 11310048. DOI: 10.3389/fphar.2024.1388753.


Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans.

Bashir M, Sherman K, Solomon D, Rosenthal A, Tedeschi S Arthritis Care Res (Hoboken). 2021; 75(2):277-282.

PMID: 34523251 PMC: 8918431. DOI: 10.1002/acr.24783.


Rheumatologists' understanding of refractory gout: a questionnaire survey in China.

Han X, Yin Y, Cao Y, Chu X, Han Y, Di H J Int Med Res. 2021; 49(5):3000605211016149.

PMID: 34038216 PMC: 8161865. DOI: 10.1177/03000605211016149.


Rapid Gout Detection Method and Kit.

Pentyala S, Monastero R, Palati S, Varghese E, Anugu A, Pentyala S Diagnostics (Basel). 2019; 9(4).

PMID: 31652657 PMC: 6963814. DOI: 10.3390/diagnostics9040157.


References
1.
Hernan M, Chen H, Schwarzschild M, Ascherio A . Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol. 2003; 54(2):170-5. DOI: 10.1002/ana.10611. View

2.
Kim S, Guevara J, Kim K, Choi H, Heitjan D, Albert D . Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 62(2):170-80. PMC: 3156692. DOI: 10.1002/acr.20065. View

3.
Ho A, Johnson M, Kingsley D . Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000; 289(5477):265-70. DOI: 10.1126/science.289.5477.265. View

4.
Bhole V, De Vera M, Rahman M, Krishnan E, Choi H . Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010; 62(4):1069-76. DOI: 10.1002/art.27338. View

5.
Choi H, Curhan G . Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008; 336(7639):309-12. PMC: 2234536. DOI: 10.1136/bmj.39449.819271.BE. View